EQL — EQL Pharma AB Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeSmall CapNeutral

Annual balance sheet for EQL Pharma AB, fiscal year end - March 31st, SEK millions except per share, conversion factor applied.

	2020 March 31st	R2021 March 31st	2022 March 31st	C2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	SAS	SAS	SAS	SAS	SAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	10.3	26.6	41.2	44.4	20.5
Net Total Accounts Receivable
Net Total Receivables	18.4	25.6	37.6	51.7	63.5
Total Inventory
Prepaid Expenses
Total Current Assets	61.3	97.8	123	167	198
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.366	5.01	4.19	3.15	2.67
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	124	204	238	286	374
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	43.4	94.9	98.8	117	162
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	43.4	112	114	131	196
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	80.9	91.2	124	155	178
Total Liabilities & Shareholders' Equity	124	204	238	286	374
Total Common Shares Outstanding